NEW YORK (Reuters Health) – Results of a small study, reported in The New England Journal of Medicine for February 21, show that treatment with
NEW YORK (Reuters Health) – The incidence of second primary colorectal cancers is high, suggesting a failure in the management of these patients, according to
ATLANTA (Reuters Health) – Women diagnosed with phenylketonuria (PKU) need to watch their protein intake during pregnancy to prevent newborn birth defects, according to a
NEW YORK (Reuters Health) – Women who undergo in vitro fertilization (IVF) are not at increased risk for cancer, according to a report published in
ATLANTA (Reuters Health) – Women diagnosed with phenylketonuria (PKU) need to watch their protein intake during pregnancy to prevent newborn birth defects, according to a
NEW YORK (Reuters Health) – A daily low dose of cyproterone acetate or a continuous monophasic oral contraceptive (OC) are both good options for the
סקירה מעתון הארץ בה מובאים מימצאים והערכות של מומחים בתחום, ביניהם גם עורכת מדור רפואת הספורט ב- e-Med, ד"ר נעמה קונסטנטיני. לכתבה
NEW YORK (Reuters Health) – Mifepristone, a pregnancy-terminating agent, can inhibit ovulation and induce amenorrhea and could, therefore, represent a novel estrogen-free oral contraceptive agent,
By Anthony J. Brown, MD NEW YORK (Reuters Health) – The risk of developing breast cancer, particularly the lobular subtype, is elevated with "recent long-term"
NEW YORK (Reuters Health) – Among women with invasive ovarian cancer, the presence of BRCA germline mutations is associated with improved survival, according to a
By Richard Woodman LONDON (Reuters Health) – Britain's National Institute for Clinical Excellence (NICE) has recommended Schering-Plough's Caelyx for the second-line treatment of advanced ovarian
NEW YORK (Reuters Health) – In a randomized, dose-response trial, a 20-cm-squared transdermal contraceptive patch (Ortho Evra) was as effective as an oral contraceptive, with
NEW YORK (Reuters Health) – Most male infertility resulting from a low serum testosterone-to-estradiol ratio can be successfully treated with the selective aromatase inhibitor, anastrozole,
NEW YORK (Reuters Health) – In couples with unexplained infertility, tubal flushing with lipiodol, an oil-soluble medium, is associated with an improved pregnancy rate, according
NEW YORK (Reuters Health) – Analysis of serum proteomic patterns can accurately identify women with ovarian cancer, regardless of the disease stage, according to a
By Martha Kerr SAN ANTONIO (Reuters Health) – Efforts to further reduce adverse risks associated oral contraceptive (OC) use by changing the progestogen component in
NEW YORK (Reuters Health) – High-dose rate vaginal brachytherapy delivered as adjuvant therapy for intermediate-risk endometrial carcinoma appears to offer similar benefit to that of
NEW YORK (Reuters Health) – Levels of C-reactive protein (CRP), an independent risk factor for cardiovascular disease, fall when obese postmenopausal women lose weight, according
STOCKHOLM (Reuters) – St. John's work, an herbal product used to treat mild depression, may counter the effect of oral contraceptive pills (OCPs) and has
By Karla Gale NEW YORK (Reuters Health) – For older postmenopausal women, hormone replacement therapy (HRT) appears to be of benefit only in those women